Health System Builds Telehealth Network; Sees Great Return on Investment

Source: Healthcare Finance News, Erin McCann (5/22/12)

"Polycom, a video conference and communications company, is helping Saint Vincent Health System build a telehealth network by visually connecting healthcare professionals and patients in virtual environments across 26 facilities in Pennsylvania."

Healthcare Finance News, Erin McCann

Bluetooth-capable stethoscopes, allowing doctors to hear heart sounds from across the country, are just one innovation Saint Vincent Health System is using in its new telehealth network, which has reduced hospital readmissions and generated a 100 percent ROI in less than two months, officials say.

Pleasanton, Calif.-based Polycom, a video conference and communications company, is helping Saint Vincent Health System build a telehealth network with technology that seeks to make healthcare more accessible by visually connecting healthcare professionals and patients in virtual environments across 26 facilities in Pennsylvania. . .View Full Article

An AI-Powered Doctor & Patient Platform: Why This North American Provider is Gaining Market Momentum
Source: Stewart Thomson (03/17/2026)

Technical Analyst Stewart Thomson explains why he likes Rocket Doctor AI Inc. (AIDR:CSE; TREIF:OTC; 939:FRA).

Biotech Expands Financing to CA$2M as AI-Driven Cancer Drug Programs Advance
Source: Streetwise Reports (02/24/2026)

Rakovina Therapeutics Inc. (RKV:TSX.V) increased its previously announced financing to approximately US$2.0 million through a convertible debenture and private placement. The company stated the proceeds will support working capital needs and ongoing corporate and strategic initiatives.

AI Collaboration Expands to Accelerate Cancer Drug Discovery
Source: Streetwise Reports (01/12/2026)

Rakovina Therapeutics Inc. (RKV:TSX.V) has broadened its partnership with Variational AI to refine next-generation ATR inhibitors using generative AI. The agreement aims to streamline lead optimization for the company's kt-5000 series of small-molecule cancer drug candidates.

Expanded AI Collaboration Advances Optimization of Cancer Drug Candidates
Source: Streetwise Reports (01/09/2026)

Rakovina Therapeutics Inc. (RKV:TSX.V) has expanded its partnership with Variational AI to advance optimization of its kt-5000 ATR inhibitor series. Learn how the agreement deepens the company's use of generative AI to refine small-molecule drug candidates and accelerate preclinical selection.